Skip to main content

rifapentine

Generic: RIFAPENTINE·Brand: PRIFTIN, Priftin

rifapentine: 4 clinical trials tracked.

rifapentine evidence translation

What we can confirm

4 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about rifapentine, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 0 study sponsors

Study sponsors

No additional listed-company sponsor is linked.

Clinical Trial Registry Records (4)

Shortened Regimen for Drug-susceptible TB in Children

NCT06253715Registry updated 2026-07-24·Phase 3
Recruiting

Primary endpoint: TB disease-free survival at 48-weeks

InterventionalRandomizedopen860 targetStarted 2025-01Completion 2027-099 sites · India, Indonesia, Mozambique, South Africa…Johns Hopkins University

Safety and Tolerability of Ultra-short Course Rifapentine and Isoniazid (1HP) for Prevention of Tuberculosis in HIV-Uninfected Individuals

NCT04703075Registry updated 2025-06-19·Phase 4
Completed

Primary endpoint: Number of Participants Who Complete Treatment With >90% Adherence

InterventionalRandomizedopen531 enrolledStarted 2022-03Completion 2024-062 sites · BrazilJohns Hopkins University

Phase I/II Dose Finding and Safety Study of Rifapentine and Isoniazid in HIV-Infected and HIV-Uninfected Children With Latent Tuberculosis Infection

NCT03730181Registry updated 2026-07-24·Phase 1/Phase 2
Completed

Primary endpoint: Rifapentine Pharmacokinetic Exposure (AUC) Following Weekly 3HP Administration

Interventionalopen69 enrolledStarted 2019-11Completion 2025-051 site · South AfricaCenters for Disease Control and Prevention

TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis

NCT00694629Registry updated 2026-08-13·Phase 2
Completed

Primary endpoint: Participants With Negative Sputum Culture at 8 Weeks

InterventionalRandomizedquadruple334 enrolledStarted 2008-12Completion 2013-1229 sites · Brazil, Canada, South Africa, Spain…Centers for Disease Control and Prevention